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Abstract
Introduction: Early pregnancy has a strong protective effect against breast cancer in humans and rodents, but the
underlying mechanism is unknown. Because breast cancers are thought to arise from specific cell subpopulations
of mammary epithelia, we studied the effect of parity on the transcriptome and the differentiation/proliferation
potential of specific luminal and basal mammary cells in mice.
Methods: Mammary epithelial cell subpopulations (luminal Sca1-, luminal Sca1+, basal stem/progenitor, and basal
myoepithelial cells) were isolated by flow cytometry from parous and age-matched virgin mice and examined by
using a combination of unbiased genomics, bioinformatics, in vitro colony formation, and in vivo limiting dilution
transplantation assays. Specific findings were further investigated with immunohistochemistry in entire glands of
parous and age-matched virgin mice.
Results: Transcriptome analysis revealed an upregulation of differentiation genes and a marked decrease in the
Wnt/Notch signaling ratio in basal stem/progenitor cells of parous mice. Separate bioinformatics analyses showed
reduced activity for the canonical Wnt transcription factor LEF1/TCF7 and increased activity for the Wnt repressor
TCF3. This finding was specific for basal stem/progenitor cells and was associated with downregulation of
potentially carcinogenic pathways and a reduction in the proliferation potential of this cell subpopulation in vitro
and in vivo. As a possible mechanism for decreased Wnt signaling in basal stem/progenitor cells, we found a more
than threefold reduction in the expression of the secreted Wnt ligand Wnt4 in total mammary cells from parous
mice, which corresponded to a similar decrease in the proportion of Wnt4-secreting and estrogen/progesterone
receptor-positive cells. Because recombinant Wnt4 rescued the proliferation defect of basal stem/progenitor cells
in vitro, reduced Wnt4 secretion appears to be causally related to parity-induced alterations of basal stem/
progenitor cell properties in mice.
Conclusions: By revealing that parity induces differentiation and downregulates the Wnt/Notch signaling ratio and
the in vitro and in vivo proliferation potential of basal stem/progenitor cells in mice, our study sheds light on the
long-term consequences of an early pregnancy. Furthermore, it opens the door to future studies assessing whether
inhibitors of the Wnt pathway may be used to mimic the parity-induced protective effect against breast cancer.
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Introduction
Pregnancy is the most significant modifiable factor
known for breast cancer risk in women. Although an
initial increase in risk occurs immediately after parturi-
tion in women older than 25 years, the overall lifetime
risk of breast cancer decreases after pregnancy [1,2].
This protective effect is > 50% if a full-term pregnancy
has occurred before the age of 20 years [1]. Similarly,
pregnancy and pregnancy-mimicking hormones have a
strong protective effect against mammary tumors in
rodents. This is true both for carcinogen-induced mam-
mary tumors [3] and for genetically engineered mouse
models of breast cancer [4].
The cellular and molecular mechanisms underlying the
breast cancer-protective effect of early pregnancy remain
unclear. Frequently raised hypotheses involve cell non-
autonomous mechanisms such as systemic changes in
circulating hormones and/or changes in the stromal com-
position of the mammary gland [5,6], and cell autonomous
processes such as changes in the differentiation state of
mammary epithelial cells [7]. Furthermore, numerous par-
ity-induced changes in gene expression have been identi-
fied in genome-wide expression profiles of entire lobular
breast tissues of women or entire mammary glands of rats
and mice [8-10]. However, it is not known to what extent
these tissue studies reflect alterations in gene-expression
profiles of distinct mammary epithelial cell subpopulations.
Hence, given that breast cancers arise from specific subpo-
pulations of mammary epithelial cells [11], investigations of
early parity-induced gene-expression changes in distinct
mammary epithelial cell subpopulations are warranted.
The mammary epithelium is hierarchically organized
into differentiated luminal and basal (myoepithelial)
cells, luminal and basal progenitor cells, and mammary
stem cells [12,13]. Whereas the latter were originally
thought to lie exclusively in the basal compartment and
to be multipotent (able to form both luminal and basal
epithelial cells), recent lineage-tracing experiments indi-
cated the existence of unipotent basal and luminal
mammary stem cells and identified multipotent mam-
mary stem cells solely in the embryonic and possibly in
the pregnant gland [14,15]. Distinct mammary epithelial
cell subpopulations, including luminal progenitor and
basal stem/progenitor cells can be isolated with fluores-
cence-activated cell sorting (FACS) by using specific
cell-surface markers from both parous and virgin mice
[16-21]. Whereas progenitor cells in general can be
characterized in vitro by their colony-forming potential
[16,22,23], the basal stem/progenitor cell subpopulation
has the additional capacity to repopulate deepithelialized
mouse mammary fat pads in vivo [16-18]. Although pre-
vious studies in total mammary epithelial cells indicated
either no change or a decrease in the mammary repopulat-
ing capacity after parity [20,21], the consequences of parity
on the transcriptome and functionality of specific
mammary epithelial cell subpopulations have not been
investigated.
Therefore, we examined in this study whether preg-
nancy alters the gene-expression profiles (“gene signa-
ture”) and the differentiation/proliferation potentials of
the various mammary epithelial cell subpopulations. The
results indicate that early parity decreases Wnt4 expres-
sion in luminal epithelial cells, leading to a reduction in
the Wnt/Notch signaling ratio specifically in basal stem/
progenitor cells. As expected, the decrease in the Wnt/
Notch signaling ratio is associated with a concomitant
strong prodifferentiation and antiproliferation phenotype
in basal stem/progenitor cells. Because a decrease in
Wnt signaling is known to have an anticarcinogenic
effect [24,25], the findings support the hypothesis that a
reduction in the Wnt/Notch signaling ratio in basal
mammary stem/progenitor cells plays a role in the miti-
gating effect of early pregnancy on breast tumorigenesis.
Methods
Animals and animal experimentation
All experiments were conducted in genetically homoge-
nous FVB/NHanHsd mice purchased from Harlan
Laboratories. The mice were bred and maintained in the
animal facility of the Friedrich Miescher Institute,
according to the Swiss guidelines on animal experimenta-
tion. All experiments were performed under permit
2159-2, in accordance with the animal-welfare ordinance
and approved by the cantonal veterinary office of Basel
Stadt, Switzerland. For the early-pregnancy protocol,
mice were time-mated when 42 days old and allowed to
lactate for 21 days. The postweaning period until cell har-
vest was 40 days, unless stated otherwise. To control for
the estrus cycle in the transcriptome analyses, at least
five mice were grouped for gland harvesting. For immu-
nohistochemical analyses and determination of blood
progesterone levels, mice in estrus were used, as assessed
by the presence of a vaginal plug after an overnight mat-
ing. Age-matched virgin control mice were maintained
under the same conditions as parous mice.
Whole mounts
Whole mounts were prepared by fixing the glands on glass
slides with methacarnoy solution (60% methanol, 30%
chloroform, 10% glacial acetic acid) for 4 hours at room
temperature. The mounts were hydrated by sequential
incubation in ethanol solutions of decreasing concentra-
tion: 100%, (overnight), 70%, 50%, and 30% (15 minutes
each), distilled water (2 × 5 minutes), and stained over-
night with an aqueous solution of 2% carmine (Sigma,
Buchs, Switzerland) and 5% aluminum potassium sulfate
(Sigma, Buchs, Switzerland). The mounts were dehydrated
in ethanol solutions (70%, 90%, 95%, and 2 × 100%, for
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15 minutes each) and cleared with xylene overnight.
Images were captured with an Epson Expression 1600 Pro
scanner.
Mammary cell preparation
The fourth mammary glands from virgin and parous
mice were collected after lymph node removal and
pooled. Mammary epithelial organoids were prepared as
described [26]. Adipocytes were removed by repeated
centrifugations (300 g). Red blood cells (RBCs) were
eliminated by incubation with 8.3 g/L ammonium chlor-
ide (pH 7.5) for 5 minutes. The number of fibroblasts in
gland extracts was reduced by their attachment to poly-
styrene cell-culture flasks (Corning, Buchs, Switzerland)
during a 45-minute incubation step in Dulbecco modi-
fied Eagle medium (Invitrogen, Zug, Switzerland) with
10% FCS (Sigma, Buchs, Switzerland) at 37°C/5% CO2
[26]. The epithelial organoids were directly processed to
single-cell suspensions by digestion in Hyclone HyQ-
Tase (ThermoScientific, Lausanne, Switzerland) with
gentle pipetting for 15 minutes at 37°C. The cell suspen-
sion was filtered through a 40-μm cell strainer (BD Fal-
con, Basel, Switzerland), and the final cell suspension
pelleted at 650 g for 4 minutes.
Cell labeling and flow cytometry
Cells were labeled as previously described [26] by using
the antibodies PE-Cy7-CD45 (1:33), FITC-CD24 (1:40),
PE-CD49f (1:40), and APC-Sca1 (1:40). Detailed antibody
information is given later. DAPI (0.2%, Invitrogen, Zug,
Switzerland) was added 10 minutes before cell sorting
(1:250). FACS was carried out on a MoFlo cell sorter (Bec-
ton Dickinson, Basel, Switzerland). Cells were gated based
on their forward- and side-scatter profiles (FS Area and SS
Area). A time-of-flight approach (pulse width) was used to
exclude doublets and higher-order cell clumps. Dead cells
(DAPI bright) and immune cells (CD45+) were gated out
(see Additional file 1). The gate for basal stem/progenitor
cells was set at the top 5% of CD49f-expressing cells, as
described [19,21] (see Figure 1). Routine examination of
the sorted mammary epithelial cell subpopulations showed
a degree of purification higher than 95%.
In vitro colony formation assay and quantification
Freshly sorted cells of each subpopulation (500 cells) were
plated onto irradiated 3T3L1 feeder cells (5,000 cells) in 24-
well Primaria plates (Becton Dickinson, Basel, Switzerland).
The cells were cultured in DMEM/Ham F12 (Invitrogen,
Zug, Switzerland) with 10% FCS, 100 IU/ml penicillin,
100 μg/ml streptomycin (Invitrogen, Zug, Switzerland),
5 μg/ml bovine pancreatic insulin (Sigma, cell culture-
tested solution, Buchs, Switzerland), 10 ng/ml mouse EGF
(BD Biosciences, Basel, Switzerland), and 10 ng/ml cholera
toxin (Sigma, Buchs, Switzerland). After 24 hours, the
medium was renewed, and 4 days later, the colonies were
fixed with acetone/methanol (1:1), washed, and rehydrated
with PBS and 0.05% NaN3. In separate rescue experiments
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Figure 1 The CD24/Sca1 and CD49fHigh/CD24 flow-cytometry
profiles of parous and age-matched virgin mice are similar.
(A) Schematic illustration of the cell-isolation strategy and
representative flow-cytometry pseudocolor plots of mammary cells
from age-matched virgin control mice. After depletion of CD45+ white
blood cells, luminal and basal mammary epithelial cells were separated
on the basis of CD24 and Sca1 expression. Further separation of basal
cells into myoepithelial and basal stem/progenitor cell subpopulations
was based on the expression of CD24 and CD49f. The isolated
mammary epithelial cell subpopulations included luminal Sca1+ (CD24
+HighSca1+) cells, luminal Sca1- (CD24+HighSca1-) cells, basal CD49fHigh
(CD24+LowSca1-CD49fHigh) or basal stem/progenitor cells, and basal
myoepithelial (CD24+LowSca1-CD49fLow) cells. (B) Outline of the
mouse mating, parturition, weaning, and involution protocol.
(C) Representative flow-cytometry pseudocolor plots of mammary cells
from parous mice. The gates applied were the same as those for age-
matched virgin controls. (D) Bar graph showing the distribution of
mammary epithelial cell subpopulations comparing cells from parous
with age-matched virgin control mice. Data represent the mean ± SEM
of seven cell-isolation experiments with a minimum of 10 mice per
experiment. The proportion of luminal Sca1+ cells was reduced by
approximately 50% in parous mice (P = 0.02 with a two-tailed
unpaired Student t test).
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the incubation medium was supplemented with recombi-
nant mouse Wnt4 (R&D Systems, Abingdon, UK) at
500 ng/ml. For quantification, colonies were immunofluor-
escently stained with Krt18 and Krt14 antibodies and with
Hoechst 33342. The stained colonies were imaged with a
MacroFluo Z16 microscope (Leica, Heerbrugg, Switzer-
land) at 2× magnification, and a Z1 microscope (Zeiss,
Feldbach, Switzerland) at 5× magnification. The feeder cells
served as negative controls for Krt18 and Krt14 staining.
The number of colonies (that is, clusters of more than
three cells [23]) per well was determined manually. Colo-
nies defined as Krt18/Krt14 double-positive were double
positive over a minimum of 20% of colony area.
Mammary fat pad transplantation
Freshly sorted basal stem/progenitor cells were resus-
pended in PBS with 50% Matrigel (BD Biosciences,
Basel, Switzerland) and injected (30 μl) in limiting dilu-
tion numbers into the cleared fourth mammary glands
of 3-week-old syngeneic female mice. Glands from reci-
pient mice were harvested 8 to 9 weeks after transplan-
tation, processed as whole mounts (see earlier), and
scanned with an Epson Expression 1600 Pro scanner.
The number of outgrowths was counted, with an out-
growth defined as an epithelial structure with ducts
starting from a central point and with lobules and/or
terminal end buds (see Additional file 2) [27].
Microarray analyses
Microarray analyses were performed on unsorted total
mammary cell suspensions (see Figure 2) and on FACS-
sorted mammary cell subpopulations (see Figures 3 and
4, as well as Table 1). For unsorted mammary cells, RNA
was extracted by using the RNeasy Plus Mini Kit (Qiagen,
Hilden, Germany). Genomic DNA was removed by using
gDNA Eliminator Mini Spin Columns (Qiagen, Hilden,
Germany). The RNA concentration was measured with a
Nanodrop 1000 machine, and RNA quality determined
with an Agilent 2100 bioanalyzer and RNA Nano Chips.
Aliquots of 100 ng of isolated total RNA were amplified
by using the Ambion WT Expression kit (Ambion, Zug,
Switzerland). For FACS-sorted mammary epithelial cell
subpopulations, total RNA was isolated by using the Arc-
turus PicoPure Frozen RNA Isolation Kit (Life Technolo-
gies, Zug, Switzerland). Genomic DNA was removed by
using RNase-Free DNase (Qiagen, Hilden, Germany), the
RNA concentration determined by using the RiboGreen
Assay, and RNA quality assessed by using an Agilent
2100 bioanalyzer and RNA Pico Chips. Total RNA was
used as the input for synthesis of amplified cDNA with
the NuGen Ovation Pico WTA System (NuGen Inc.,
Leek, The Netherlands).
Resulting double-stranded cDNA was fragmented and
labeled by using the Affymetrix GeneChip WT Terminal
Labeling kit (Affymetrix, High Wycombe, UK). Affyme-
trix Gene Chip Mouse gene 1.0 ST microarrays were
hybridized according to the GeneChip Whole Transcript
(WT) Sense Target Labeling Assay Manual (Affymetrix,
High Wycombe, UK) with a hybridization time of
16 hours. The Affymetrix Fluidics protocol FS450_0007
was used for washing. Scanning was performed with
Affymetrix GCC Scan Control Software v. 3.0.0.1214 on
a GeneChip Scanner 3000 7 G with autoloader. Arrays











































































































































































































Figure 2 Parity-induced gene signature in total mammary cell
suspensions. (A) Heat-map and cluster analysis of differential gene
expression in total isolated mammary cells from age-matched virgin
control and parous mice. Gene expression is presented as
normalized Z-scores, defined as Z = (x-μ)/sd to allow visualization.
A cut-off of P < 0.05 was applied. If multiple probe sets existed for
the same gene, the probe set with the largest change in expression
was selected. Four independent experiments were performed with
10 mice (five virgins; five parous) per experiment. (B) qPCR
validation of pregnancy-induced gene-expression changes in total
mammary cell suspensions. Fold changes are shown in relation to
expression in cell suspensions from age-matched virgin control
mice. Ct values were normalized to the reference gene Hprt. As
control for luminal epithelial cell number, qPCR for Krt8 was
performed. Data represent the mean ± SEM of four independent
experiments with 10 mice (five virgins; five parous) per experiment.
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calculated with R/Bioconductor’s (v2.14) “affy” package
by using the rma() function. Differential gene expression
between experimental and control samples was deter-
mined by using linear modeling as implemented in the
R/Bioconductor package “limma.” For general analysis of
gene expression in total mammary cell suspensions and
in FACS-sorted mammary cell subpopulations, we used
the cut-off linear fold change > 1.5, adjusted P value <
0.05, and average linear expression between conditions
greater than 4. To determine the 10 most up- or down-
regulated genes in FACS-sorted mammary epithelial cell
subpopulations, a cut-off of linear fold change > 2.0,
adjusted P value < 0.001, and average linear expression
between conditions ave > 4 was used. For FACS-sorted
mammary epithelial cell subpopulations both resulting
Figure 3 Parity leads to differentiation and decreases the Wnt/
Notch signaling ratio in basal stem/progenitor cells. (A) Bar graph
depicting the number of gene-expression changes in FACS-sorted
mammary stromal and epithelial cell subpopulations from parous mice
compared with age-matched virgin control mice by using a cut-off of
fold change > 1.5 and an adjusted P value < 0.05. By far the most
gene-expression changes were observed in basal stem/progenitor
cells. Three independent experiments were performed with 10 mice
(five virgins; five parous) per experiment. (B) Schematic illustration of
prominent gene-expression changes in FACS-sorted basal stem/
progenitor cells from parous as compared with age-matched virgin
control mice. Fold changes are shown in parentheses with
upregulated genes denoted as positive (+), and downregulated genes,
as negative (-). Differentiation genes were upregulated (blue), Wnt
target genes were downregulated (green), Wnt inhibitor Sfrp1 was
upregulated (green) and overall Notch signaling (orange) was
increased in basal stem/progenitor cells from parous mice. (C) qPCR
validation of the changes in gene expression in basal stem/progenitor
cells of parous mice. All classic Wnt target genes were downregulated,
including Lgr5, Axin2, and versican (Vcan), whereas the more
ubiquitously regulated target Myc was unchanged. In all cases, fold
changes are shown relative to cells from age-matched virgin control
mice. Ct values were normalized to the reference genes Hprt and Ubc
[63]. Data represent the mean ± SEM of three independent
experiments with 10 mice (five virgins; five parous) per experiment.
(D) Representative images and quantification of immunostaining for
the Wnt target gene versican in mammary gland sections from age-
matched virgin and parous mice in estrus. Scale bar, 50 μm.
Quantitative data represent the mean ± SEM from 60 randomly
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Figure 4 Effects of parity on Wnt transcription-factor activities
and nuclear b-catenin in basal mammary epithelial cells. (A) Wnt
transcription factor LEF1/TCF7 motif activity in basal stem/progenitor
cells from parous as compared with virgin control mice, as predicted
by MARA [32]. The binding motif of the LEF1/TCF7 transcription factor
is shown in color. (B) Representative images of immunostaining for
b-catenin in mammary gland sections from age-matched virgin and
parous mice in estrus. Arrow, basal mammary epithelial cells with
nuclear b-catenin. Arrowhead, basal mammary epithelial cells lacking
nuclear b-catenin. Scale bar, 10 μm. (C) Bar graph representing the
quantification of nuclear b-catenin in mammary gland sections of
virgin and parous mice. Data represent the mean ± SD (virgin mice:
n = 3; parous mice: n = 3). P = 0.004 with the two-tailed unpaired
Student t test. (D) Transcription-factor activities in basal stem/
progenitor cells, predicted on the basis of target gene expression by
Ingenuity IPA [40]. Activity is reported as Z scores (positive Z score,
upregulation; negative Z score, downregulation) by using a cut-off of
linear fold change > 1.5 and P value < 0.05. (E) BioFunctions most
strongly downregulated (blue) or upregulated (orange) in basal stem/
progenitor cells, as calculated by Ingenuity IPA [40]. The color of the
fields represents the Z score; the size of the fields represents the
number of genes. A stringent cut-off of linear fold change > 2 and
P value < 0.01 was used to minimize the number of false positives.
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lists of differential genes were imported into Ingenuity IPA
(Ingenuity, content version 12710793) for pathway analy-
sis. Gene-set enrichments in FACS-sorted mammary
epithelial cell subpopulations were determined by using
the JAVA application from the Broad Institute v2.0 [28,29]
and gene sets v2.5 and v3.0, as well as custom gene sets
(see Additional file 3).
The microarray data from this publication have been
submitted to the NCBI Gene Expression Omnibus [30]
and are deposited as GSE40875 (mouse mammary cell
subtypes), GSE40876 (total mammary epithelial cells in
mice), and GSE40877 (both total mammary epithelial cells
and mammary cell subtypes in mice).
Quantitative PCR
RNA was isolated as described earlier and converted to
cDNA by using the WT-Ovation Exon Module Version
1.0 (NuGen Inc., Leek, The Netherlands). Real-time PCR
was performed on the unamplified cDNA corresponding
to the specified number of cells or on 25 ng of amplified
cDNA (by using the NuGen Ovation Pico WTA System
(NuGen Inc., Leek, The Netherlands) for amplification).
The TaqMan probe-based system was applied in combina-
tion with the TaqMan Universal PCR Master Mix
(Applied Biosystems, Zug, Switzerland). The probe IDs are
given later. Cycling was performed with 7500 Fast and
Step OnePlus Real-Time PCR Systems (both from Applied
Biosystems, Zug, Switzerland).
Probe IDs for quantitative PCR
These were the probes: Areg (Mm00437583_m1), Axin2
(Mm00443610_m1), B2M (Mm00437762_m1), Cdk8
(Mm01223097_m1), Cel (Mm00486975_m1), Csn1s1
(Mm00514430_m1), Csn2 (Mm04207885_m1), Dsc2
(Mm00516355_m1), Dusp1 (Mm00457274_g1), Esr1
(Mm00433149_m1), Fst (Mm00514982_m1), Gata3
(Mm00484683_m1), Hprt (Mm00446968_m1), Id3
(Mm00492575_m1), Igfbp3 (Mm_01187817_m1), Jag2
(Mm01325629_m1), Krt8 (Mm00835759_m1), Krt14
(Mm00516876_m1), Krt15 (Mm00492972_m1), Krt19
(Mm00492980_m1), Lgr5 (Mm00438890_m1), Ltf
(Mm00434787_m1), Maml2 (Mm00620617_m1), Myc
(Mm00487804_m1), Pgr (Mm00435628_m1), Sfrp1
(Mm00489161_m1), Ubc (Mm01201237_m1), Vcan
(Mm01283063_m1), Wnt4 (Mm01194003_m1).
Immunofluorescent staining
For single-cell staining, freshly sorted cells were allowed to
air-dry on poly-L-lysine-coated slides and stored at -20°C.
The dried cells were blocked with PBS, 2.5% goat serum,
and 0.05% NaN3 for 60 minutes under UV light. The UV
treatment was used to attenuate residual fluorescence
from bound FACS antibodies. Primary antibody staining
was performed overnight at 4°C by using Krt18 antibody
(1:1,000) and Krt14 antibody (1:500) as luminal and basal
cell markers, respectively. Secondary antibody staining was
carried out for 60 minutes at room temperature by using
anti-guinea pig Ig-Alexa488 (1:500) and anti-rabbit Ig-
Alexa546 (1:1,000). Hoechst 33342 (0.5 μg/ml; Invitrogen,
Zug, Switzerland) staining was performed for 10 minutes
at room temperature. The stained cells were mounted
with ProLong Gold antifade reagent (Invitrogen, Zug,
Switzerland) and imaged with a Z1 microscope (Zeiss,
Feldbach, Switzerland) at 63× magnification. No primary
antibody was added as a negative control.
Immunohistochemistry
The fourth mammary glands of parous or age-matched vir-
gin control mice were collected 40 days after weaning from
mice in estrus. The glands were fixed in 4% PFA and
embedded in paraffin. For immunostaining with ERa and
PR, the sections were dewaxed and subjected to antigen
retrieval by boiling in 10 mM citrate buffer for 10 minutes.
Subsequently, the sections were cooled to room tempera-
ture, quenched for 10 minutes with PBS and 3% H2O2, and
blocked for 30 to 60 minutes with PBS and 2.5% NGS. ERa
and PR primary antibody staining was performed overnight
at 4°C at a 1:1,000 (ERa) and a 1:200 (PR) dilution. Second-
ary antibody staining was carried out for 30 to 60 minutes
at room temperature with biotinylated anti-rabbit IgG.
Table 1 Wnt signaling is decreased and Notch signaling is upregulated in basal stem/progenitor cells
Wnt signaling Notch signaling
NES P value FDR FWER NES P value FDR FWER
Myoepithelial -1.47 0.03 0.06 0.04 1.08 0.35 0.34 0.74
Basal stem/progenitor -1.70 < 0.01 < 0.01 < 0.01 1.64 < 0.01 0.02 0.01
Luminal Sca1- -1.08 0.33 0.64 0.37 1.08 0.32 0.62 0.45
Luminal Sca1+ -0.68 0.99 0.99 0.74 0.83 0.77 1.00 0.93
Gene-set enrichment analysis (GSEA) for Wnt and Notch signaling, as defined by the expression of Wnt or Notch target genes (see Methods) showed a decrease
in the Wnt/Notch signaling ratio (strongly negative/positive normalized enrichment scores (NES)), which was specific for the basal stem/progenitor cells.
Significance was determined by a cut-off of a nominal P value < 0.01, a false-discovery rate (FDR) < 0.05, and a family-wise error rate (FWER) < 0.05, as suggested
by the GSEA homepage [28]. The gene set for Wnt signaling consisted of the reported Wnt targets in mammalian systems (derived from the Stanford Wnt
homepage) and is depicted in Additional file 3. The gene set for Notch signaling was derived from the Broad Institute v3.0 and is termed Nguyen Notch1 targets.
The number of permutations was set to 1,000, and the permutation type was set to “gene set,” because fewer than seven samples existed per phenotype [28].
Otherwise, the default settings were used.
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Immunohistochemistry for versican, b-catenin, and p21
was performed on the Ventana DiscoveryXT instrument
(Roche Diagnostics, Rotkreuz, Switzerland) by using the
Research IHC Dap Map XT procedure. In brief, dewaxing
was performed in the machine, and slides were pretreated
with mildCC1 (versican and p21) or standardCC1 (b-cate-
nin) (Roche Diagnostics, Rotkreuz, Switzerland). Primary
antibodies were incubated at 37°C for 1 hour at the follow-
ing dilutions: versican, 1:50; p21, 1:50; and b-catenin, 1:500.
As secondary antibody, Immpress, an anti-rabbit HRP con-
jugated polymer, was used. All slides were counterstained
with Hematoxylin II (Roche Diagnostics, Rotkreuz, Switzer-
land) and Bluing Reagent (Roche Diagnostics, Rotkreuz,
Switzerland). Images were captured at 20-fold (ERa or PR)
or 40-fold (versican, b-catenin, p21) magnification by using
an Eclipse E600 microscope (Nikon, Egg, Switzerland). For
quantification of ERa and PR positivity, at least 2,000
epithelial cells per mouse were counted. For quantification
of nuclear b-catenin and p21, at least 500 epithelial cells
per mouse were counted. The quantification of versican
was performed with the MATLAB software by using color
segmentation based on Mahalanobis distance to determine
the pixels with a particular RGB-color distribution [31].
Determination of blood progesterone concentrations
Blood was collected from the right atrium of mice in
estrus in EDTA-covered tubes (Sarstedt, Numbrecht-
Rommelsdorf, Germany), and plasma was extracted by
centrifugation at 1,500 g for 15 minutes at 4°C. Progester-
one concentrations were assessed with ELISA, as specified
by the manufacturer’s guidelines (DRG, catalog no. EIA-
1561, Marburg, Germany).
Antibodies
For flow cytometry, the following anti-mouse antibodies
were used: PE-Cy7-CD45 (clone 30-F11), FITC-CD24
(clone M1/69), PE-CD49f (clone GoH3) (all from BD
Pharmingen, Basel, Switzerland), and APC-Sca1 (clone
E13-161.7, from Biolegend, San Diego, USA).
For immunofluorescence staining, the primary anti-
mouse antibodies used were guinea pig keratin 18 (Krt18;
Fitzgerald; catalog no. GP11, North Acton, USA) and rab-
bit keratin 14 (Krt14; ThermoScientific, catalog no. RB-
9020, Lausanne, Switzerland). The secondary antibodies
used were anti-guinea pig Ig-Alexa488 and anti-rabbit Ig-
Alexa546 (Molecular Probe, Invitrogen, Zug, Switzerland).
For immunohistochemistry staining, the primary anti-
bodies included estrogen receptor alpha (ERa; Santa
Cruz Biotechnology; catalog no. SC-542, Dallas, USA),
progesterone receptor (PR; Clone SP2, ThermoScientific;
catalog no. RM-9102, Lausanne, Switzerland), versican
(Millipore/Chemicon; catalog no. ab1033, Billerica, USA),
b-catenin (Cell Signaling; catalog no. 9587, Danvers,
USA), and p21 (Abcam; catalog no. ab2961, Cambridge,
UK). The secondary antibodies used were biotinylated
anti-rabbit IgG (Vector Labs; catalog no. BA-1000,
Petersborough, UK) and anti-rabbit HRP conjugated
polymer Immpress (Vector Labs; catalog no. MP-7401,
Petersborough, UK).
Statistics
The limited dilution transplantation data were analyzed
statistically as published previously [18]. The two-tailed
unpaired Student t test was used to determine statistical
significance of comparisons.
Motif Activity Response Analysis (MARA)
The MARA model [32] combines knowledge of gene-
expression levels (measured by microarray) with transcrip-
tion-factor binding sites to answer the question of which
transcription factors are driving expression changes in
mammary stem/progenitor cells in parous as compared
with age-matched virgin control mice. Specifically, log-
expression levels of all genes present on the microarray
were modeled as linear combinations of transcription fac-
tor activities. The coefficients of these combinations were
determined by the number of transcription-factor binding
sites in the proximal promoter regions. For each transcrip-
tion-factor binding motif m and each sample (microarray)
s, we estimated the activity Ams with the corresponding
error. Furthermore, we quantified the significance of activ-
ity change of each binding motif in parous as compared
with virgin control mice.
Results
Early pregnancy decreases luminal Sca1+ cells, but does
not change the proportions of the other mammary
epithelial cell subpopulations
To investigate the influence of early parity on the propor-
tions of mammary epithelial cell subtypes, we first estab-
lished FACS profiles of epithelial cell subpopulations in
virgin FVB control mice [21,26]. Luminal CD24+High Sca1+
cells, luminal CD24+High Sca1- cells, basal CD24+Low Sca1-
CD49fHigh cells, and basal CD24+Low Sca1- CD49fLow myoe-
pithelial cells were isolated from these mice (Figure 1A).
Use of the established cell markers keratin 18 (Krt18) and
keratin 14 (Krt14) confirmed the luminal and basal origin
of the isolated cell subpopulations, and qPCR for CD49f
and Sca1 affirmed the purity of the isolated cell subpopula-
tions (see Additional file 4). Because basal CD49fHigh cells
are considered to be enriched for basal mammary stem/
progenitor cells in virgin mice [19,21], the term “basal
CD49fHigh cells” is used synonymously with “basal stem/
progenitor cells” throughout this article. To extend these
analyses to parous mice, we confirmed that involution was
complete 28 and 40 days after weaning (see Additional
file 5). To allow a margin of safety, 40 days after weaning
was used for all subsequent cell-isolation experiments in a
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standardized parturition protocol with mating at 42 days
(Figure 1B). The FACS profiles of epithelial cell subpopula-
tions from parous mice and age-matched virgin control
mice were similar (Figure 1C, D; Additional file 1) with the
exception of luminal Sca1+ cells, which decreased by about
50% in parous mice (P = 0.02). Of note, luminal Sca1+ cells
have been shown to be enriched for hormone receptor-
positive cells [17]. This was verified by qPCR (see Addi-
tional file 6). These data demonstrate that the adopted
experimental procedure permits the isolation of all epithe-
lial cell subpopulations from parous mice, including basal
stem/progenitor cells, at levels adequate for transcriptomic
and functional analyses.
Parity upregulates differentiation genes in all cell
subpopulations and decreases the Wnt/Notch signaling
ratio in the basal stem/progenitor cell subpopulation
Next we investigated the effects of early pregnancy on
the gene-expression profiles of the isolated mammary
epithelial cell subpopulations. To control for the effect
of the cell-isolation procedure on gene expression, we
performed first a transcriptome and cluster analysis in
non-FACS-sorted total mammary cell suspensions from
age-matched virgin and parous mice (Figure 2A). The
analysis showed that pregnancy induces an upregulation
of many immunoglobulin and differentiation genes (for
example, whey acidic protein Wap, and carboxyl ester
lipase Cel) and a downregulation of growth factors (for
example, amphiregulin Areg, betacellulin Btc, tumor-
associated calcium signal transducer 2 Tacstd2), and
extracellular matrix (ECM) elements (for example, lami-
nin, gamma 2 Lamc2, desmocollin 2 Dsc2). These data
are consistent with the published pregnancy-induced
gene signature determined in snap-frozen rodent mam-
mary glands [9,10]. Thus, the gene signature was not
lost during the isolation procedure, confirming the
validity of our experimental system. Furthermore and
most interestingly, a novel 3.4-fold downregulation of
the Wnt signaling protein Wnt4 was observed in cells
from parous mice (Figure 2). These microarray data
were validated by qPCR for four genes, including Wnt4.
Importantly, the expression of the luminal marker Krt8
was not altered on parity, demonstrating that the
observed changes in gene expression were independent
of unspecific alterations in total luminal cell numbers
(Figure 2B).
Because the number of isolated basal stem/progenitor
cells for gene-profiling analysis was limited compared
with the other cell subpopulations (that is, myoepithelial,
luminal Sca1-, and luminal Sca1+ cells), it was important
to evaluate the influence of different cell numbers on
transcriptome analysis. As shown in Additional Material,
we found that it is valid to use cell numbers in the range
of 2,000 to 50,000 cells for comparison of transcriptomes
from different mammary cell subpopulations (Additional
file 6). Furthermore, qPCR analysis of nonamplified and
amplified cDNA for known basal (Krt14) and luminal
(Krt8; Krt19) cell marker genes confirmed that the ampli-
fication process of the microarray analysis was unbiased
(Additional file 6).
In the subsequent transcriptome analysis of FACS-
sorted mammary epithelial cell subpopulations from age-
matched virgin control and parous mice, all mammary
epithelial cell subpopulations, except immune cell-
depleted stromal cells, showed parity-induced changes in
gene expression with by far the most prominent effects
being scored for basal stem/progenitor cells (Figure 3A).
Furthermore, although differentiation genes were upre-
gulated in all epithelial cell subpopulations, the strongest
prodifferentiation effects were seen in basal stem/pro-
genitor cells from parous mice. For example, casein alpha
1 (Csn1s1), casein beta (Csn2), and lactotransferrin (Ltf)
were upregulated 41-, 19-, and 14-fold, respectively
(Figure 3B). Apart from these differentiation genes, the
Notch co-activator Maml2 was found among the 10
most-upregulated genes (by fold change and/or by P
value) in basal stem/progenitor cells from parous mice.
In contrast, the 10 most-downregulated genes included
the Wnt target and co-receptor Lgr5, the Wnt target
and epithelial stem cell marker keratin 15 (Krt15) [33],
and the Wnt targets versican (Vcan) and Igfbp3 [34]
(Figure 3B). Extension of the analysis to all data for sig-
naling-pathway genes revealed further Wnt target genes,
which were downregulated (for example, CD44 and follis-
tatin (Fst) [35,36]), and the Wnt inhibitor Sfrp1, which
was upregulated in basal stem/progenitor cells from
parous mice. Moreover, in the same epithelial cell subpo-
pulation of parous mice, the Notch ligand Jag2 and the
Notch target genes Gata3, Id3, and Dusp1 were upregu-
lated, whereas the Notch inhibitor Itch and the Maml2
RBP-J complex inhibitors Cdk8 and Pak1 [37] were
downregulated (Figure 3B). These gene-expression profil-
ing data were validated with qPCR for several selected
genes (Figure 3C). Furthermore, one of the classic Wnt
target genes (versican) was examined on the protein level
and found to be strongly downregulated in the basal
compartment of mammary glands from parous mice
(Figure 3D). Thus, the data demonstrate strong upregula-
tion of differentiation genes, a downregulation of Wnt
target genes, and an increase in Notch signaling in the
basal stem/progenitor-cell subpopulation of parous mice.
Further verification of these conclusions came from
Motif Activity Response Analysis (MARA) of transcrip-
tion factor activities (see Methods) [38]. The canonical
Wnt transcription factor LEF1/TCF7 was shown to have
significantly decreased activity in basal stem/progenitor
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cells from parous mice (Figure 4A), which is consistent
with the observed decrease in canonical Wnt signaling
in the previous gene-expression profile analysis.
Final confirmation of parity-induced downregulation of
Wnt signaling in mammary glands was provided by immu-
nohistochemical staining of mammary gland sections from
age-matched virgin control and parous mice for b-catenin.
As illustrated in Figure 4B, nuclear b-catenin was observed
in basal but not in luminal mammary epithelial cells of
virgin mice. In parous mice, the proportion of basal mam-
mary epithelial cells positive for nuclear b-catenin was
significantly decreased (Figure 4C). Because nuclear
b-catenin is necessary for Wnt target gene expression, this
finding represents an additional verification of parity-
induced downregulation of Wnt signaling (Figure 3).
The parity-induced decrease in Wnt/Notch signaling ratio
is specific for the basal stem/progenitor cell
subpopulation
To assess whether the observed decrease in canonical Wnt
and increase in Notch signaling were specific for basal
stem/progenitor cells, we next investigated the enrichment
of Wnt/Notch signaling genes over all genes altered in the
various FACS-sorted mammary epithelial cell subpopula-
tions from parous as compared with virgin control mice.
Such analysis showed that canonical Wnt signaling was
significantly downregulated in basal stem/progenitor but
not in luminal Sca1- or luminal Sca1+ cells from parous
mice (Table 1; see Additional file 7). In myoepithelial cells,
a trend toward a decrease in Wnt signaling was not signifi-
cant when applying a very stringent cut-off (see Table 1
legend) and was probably due to contamination of the
myoepithelial cell subpopulation with basal stem and/or
progenitor cells. Similarly, Notch signaling was found to
be significantly upregulated in basal stem/progenitor cells
but in no other mammary epithelial cell subpopulation
(Table 1). Whereas downregulation of Wnt and upregula-
tion of Notch signaling were specific for basal stem/pro-
genitor cells, similar enrichment analyses for genes
involved in other signaling pathways revealed that the pre-
viously reported upregulation of the p53-p21 pathway [39]
occurred in all epithelial cell subpopulations tested (Addi-
tional file 7).
Further bioinformatics analysis of the data with differ-
ent software [40] provided a second line of verification
of the specific decrease in Wnt signaling in basal stem/
progenitor cells after parity. Performing transcription-
factor activity analyses based on target gene expression,
we found TCF3, an inhibitor of the canonical Wnt sig-
naling pathway [41], to be the transcription factor with
the highest z-score (Z = 3.521) and the protooncogene
MYC to have a very low z-score (Z = -4.108) in basal
stem/progenitor cells but not in other mammary epithe-
lial cell subpopulations of parous mice (Figure 4D,
z-score defined as (x-μ)/sd and used as a measure for
transcription factor activity based on the expression
levels of target genes). These findings confirm the
results obtained in the MARA analysis. Furthermore,
inhibition of MYC leads to upregulation of Sfrp1, which
in turn inhibits canonical Wnt signaling [42]. Upregula-
tion of Sfrp1 was observed in the microarray analysis
and validated with qPCR (Figure 3B, C), thus directly
reflecting the expected effects of the bioinformatic
predictions.
Downregulation of canonical Wnt signaling and MYC
activity would be expected to decrease the propensity for
cancer, and indeed, in an analysis of biofunctions, a
marked and consistent decrease in cancer-associated
functions, was observed for basal stem/progenitor cells
(Figure 4E), but no other mammary epithelial cell subpo-
pulation. This potential anticancer phenotype of basal
stem/progenitor cells was underscored by gene-enrich-
ment analyses on all available pathway gene sets (see
Additional file 8), which showed a strong downregulation
of proliferation- and tumorigenesis-associated gene sets.
Parity decreases the in vitro clonogenic potential to the
greatest extent in the basal stem/progenitor cell
subpopulation
Because decreased Wnt signaling and increased Notch sig-
naling have been shown to decrease in vitro and in vivo
proliferation of basal stem/progenitor cells [43,44], we next
assessed the in vitro colony-formation capacities of mam-
mary epithelial cell subpopulations from parous and age-
matched virgin mice (Figure 5A). In virgin control mice,
luminal Sca1- cells had the highest colony-formation capa-
city, with an average of 107 colonies per well (Figure 5B).
This strong clonogenic potential suggests a pronounced
progenitor identity of luminal Sca1- cells and is consistent
with previous observations in younger virgin mice [16,17].
A high colony-formation capacity was also observed for
the basal stem/progenitor cells of virgin mice (63 colonies
per well) (Figure 5B), which is consistent with the notion
that CD49fHigh cells contain a high proportion of basal pro-
genitor cells as well as putative mammary stem cells [45].
With the exception of luminal Sca1- cells, the colony-
formation capacities of all epithelial cell subpopulations
were lower in parous mice than in age-matched virgins
(Figure 5B). Thereby, by far the most pronounced difference
was observed in basal stem/progenitor cells (Figure 5B).
A substantial decrease in the colony-formation capacity was
also seen for the myoepithelial cell subpopulation, which
also contains basal progenitor cells. Of note, basal stem/pro-
genitor cells from parous mice did not die but remained as
quiescent single cells or divided only once during 5 days of
culture (Figure 5C).
The reduced progenitor potential of basal mammary
epithelial cell subtypes and especially of basal stem/
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progenitor cells from parous mice was further confirmed
by phenotypic analysis of colonies by colony size (cell
number) and immunophenotyping of luminal and basal
markers Krt18 and Krt14, respectively. The largest dif-
ference in colony size was observed for the basal stem/
progenitor cell subpopulation, where parity induced a
decrease in colonies of ≥ 20 cells from 66% to 9%
(Table 2A; Figure 5C). Considerably smaller parity-
induced reductions in colony size were observed for the
other epithelial cell subpopulations, although a substan-
tial decrease was also seen for basal myoepithelial cells
(Table 2A). With regard to Krt18/Krt14 double positiv-
ity, parity induced a reduction in Krt18/Krt14 double-
positive colonies derived from basal stem/progenitor
cells from 26% to 0 (Table 2A). In contrast, although
Krt18/Krt14 double-positivity decreased by 27%, 57% of
colonies derived from luminal Sca1- cells of parous mice
maintained double positivity (Table 2A). No effects of
parity on Krt18/Krt14 double positivity were observed
for colonies derived from luminal Sca1+ or basal myoe-
pithelial cells (Table 2A), whereby myoepithelial cells
did not give rise to double-positive colonies even when
originating from virgin control mice. Thus, consistent
with the basal mammary stem/progenitor cell subpopu-
lation-specific reduction in the Wnt/Notch signaling
ratio, parity decreased colony-formation capacity, in
vitro proliferation potential (colony number and size),
and Krt18/Krt14 double positivity most prominently in
the basal stem/progenitor cell subpopulation.
Parity decreases the in vivo reconstitution efficiency of
the basal stem/progenitor cell subpopulation
To test their proliferation potential in vivo, we trans-
planted basal stem/progenitor cells into deepithelialized
mammary glands ("cleared fat pads”) [12]. It already was
demonstrated that basal CD49fHigh cells have the highest
mammary gland reconstitution ability of all mammary cell
subpopulations in virgin mice [16,19]. Transplantation of
FACS-isolated basal stem/progenitor cells into cleared fat
pads demonstrated a significant decrease in the number of
large outgrowths (≥ 10% and ≥ 25% of fat pad filled), indi-
cating a decrease in the in vivo proliferation potential.
Interestingly, when assessing also for rudimentary out-
growths (≥ 3% of fat pad filled), no significant difference in
the number of outgrowths was observed between parous
and virgin donors (Table 2B). Apart from the change in
size, no qualitative differences were apparent between out-
growths from virgin and parous donors. In both cases,
ductal as well as lobular structures were formed. Hence,
early parity led to a reduction in in vivo mammary repopu-
lating efficiency of FACS-isolated basal stem/progenitor
cells, whereas their ability to differentiate into different
mammary epithelial structures was maintained.
Decrease in the proportion of Wnt4-secreting cells after
early parity can explain decreased Wnt signaling and
reduced proliferation capacity in basal mammary
stem/progenitor cells
Having observed most of the expected functional conse-
quences of a decrease in the Wnt/Notch signaling ratio in
basal stem/progenitor cells from parous mice, we finally
examined the possible cause of parity-induced reduction
in canonical Wnt signaling and proliferation capacity in
basal stem/progenitor cells. Because parity induced a
greater than threefold decrease in Wnt ligand Wnt4 gene
expression (Figure 2A, B), and Wnt4 is known to be
secreted in response to progesterone by hormone-sensing
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Figure 5 Parity reduces the progenitor potential of mammary
epithelial cell subpopulations. (A) Representative images of
individual wells with colonies formed by the specified cell
subpopulations from age-matched virgin and parous mice. Scale
bar, 4 mm. (B) Bar graph comparing the colony-forming capacities
of myoepithelial cells, basal stem/progenitor cells, luminal Sca1-, and
luminal Sca1+ cells of age-matched virgin and parous mice. Data
are from three independent experiments and represent the mean ±
SEM of colonies per well; 18 wells were assessed per cell type. *P <
0.015, NS: not significant (P = 0.08), by using two-tailed unpaired
Student t test. (C) Representative images for the
immunophenotyping of 5-day-old colonies grown from
myoepithelial cells, basal stem/progenitor cells, luminal Sca1-, and
luminal Sca1+ cells. The colonies were stained for luminal Krt18
(green) and basal Krt14 (red) expression. Hoechst 33342 (blue) was
used to distinguish nuclei and to label feeder cells (negative
control). Scale bar, 200 μm.
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in mammary stem/progenitor cells [47], a parity-induced
decrease in estrogen/progesterone-sensitive luminal cells
could explain the overall decrease in Wnt signaling in
mammary stem cells. This hypothesis is supported by the
reduction in the proportion of luminal Sca1+ cells isolated
from parous mice (Figure 1D) and by the demonstration
that luminal Sca1+ cells are hormone receptor positive
(Additional file 6) [17]. Furthermore, immunohistochem-
ical analysis of mammary gland sections for estrogen
receptor alpha (ERa) and its target progesterone receptor
(PR) showed a twofold decrease in ERa- and a threefold
decrease in PR-positive cells in parous compared with age-
matched virgin control mice (Figure 6A, B). These results
were additionally verified by qPCR in total mammary cell
suspensions (Figure 6C). Notably, expression of the lumi-
nal marker Krt8 was similar in cell suspensions from par-
ous and age-matched virgin control mice, supporting the
conclusion of a specific decrease in hormone receptor-
positive cells rather than a general cell loss after preg-
nancy. Furthermore, parity-induced reduction in proges-
terone-stimulated Wnt4 expression was independent of
blood progesterone, because average blood progesterone
concentrations were similar in parous mice and age-
matched virgin control mice in estrus (see Additional
file 9). Finally, supplementation of the culture medium
with recombinant Wnt4 stimulated in vitro proliferation
capacity of basal myoepithelial and basal stem/progenitor
cells from parous mice by +138% ± 22% and +140% ±
17%, respectively (Figure 7A). In contrast, no significant
effects of recombinant Wnt4 on the colony-formation
capacity of luminal Sca1- (+3.7% ± 3.0%) and luminal
Sca1+ cells from parous mice (-5.1% ± 2.9%) were
observed. These data strongly suggest a causal relation
between reduced number of luminal progesterone recep-
tor-positive/Wnt4-secreting cells and decreased Wnt/
Notch signaling and proliferation potential of basal stem/
progenitor cells after early pregnancy (Figure 7B).
In conclusion, all collected data indicate that early parity
induces a decrease in luminal hormone-sensing ERa-
and PR-positive cells, which leads to decreased Wnt4
expression levels and to reduced Wnt signaling in basal
stem/progenitor cells. Consistent with the decrease in the
Wnt/Notch signaling ratio, differentiation is promoted
and proliferation inhibited in basal stem/progenitor cells
of parous mice.
Discussion
This study demonstrates that a history of early pregnancy
changes the gene-expression profiles and functional
properties of mammary epithelial cell subpopulations in
Table 2 Functional characterization of isolated epithelial cell subpopulations
A Fraction of large colonies Fraction of double-positive
colonies
Virgins Parous Virgins Parous
Myoepitheliala 32.7 ± 7.4%a 9.6 ± 2.3%a 0% 0%
Basal stem/progenitora 66.2 ± 7.2%a 9.3 ± 4.5%a 26.1 ± 2.7% 0%
Luminal Sca1-b 36.3 ± 5.6%b 31.3 ± 2.6%b 84.0 ± 3.4% 57.1 ± 2.9%
Luminal Sca1+a 73.3 ± 1.8%a 71.8 ± 4.1%a 64.1 ± 3.6% 59.8 ± 2.7%
B
Number of basal stem/progenitor cells injected per cleared fat pad




1,000 c8/9 d8/9 e8/9 c3/9 d3/9 e4/9
500 c8/11 d8/11 e8/11 c2/11 d2/11 e6/11
250 c2/6 d2/6 e2/6 c0/6 d1/6 e1/6
100 c0/6 d1/6 e1/6 c0/6 d0/6 e2/6
50 c0/7 d0/7 e0/7 c1/7 d1/7 e1/7
Repopulating frequency (95% confidence interval) c1/507 (1/827 - 1/311) c1/2468 (1/5,522 to 1/1104)
d1/472 (1/767 - 1/291) d1/2095 (1/4,441 to 1/988)
e1/472 (1/767 - 1/291) e1/907 (1/1582 - 1/520)
P value cP = 0.0004; dP = 0.0004; eP = 0.076.
A: Size and phenotype (Krt18/Krt14 double positivity) of colonies. At least 50 randomly selected colonies were examined for each group, except for colonies
derived from basal stem/progenitor cells of parous mice, where all available colonies were used. Data represent the mean ± SEM of three independent
experiments with a minimum of 10 mice (five virgins; five parous) per experiment. aColony size ≥ 20 cells; bColony size ≥ 100 cells. B: Limiting dilution analysis of
the repopulating capacity. The basal stem/progenitor cell subpopulations from parous (n = 23) and age-matched virgin control (n = 21) mice were injected into
the cleared fat pads of 3-week-old syngeneic female recipient mice in limiting dilution numbers. Epithelial outgrowths were scored 8 to 9 weeks after injection.
Number of positive outgrowths of specified sizes is indicated per number of mammary fat pads injected (that is, X outgrowths per Y injections = X/Y). When
analyzed statistically, as previously described [18], a significant decrease in the number of large outgrowths was observed for parous donors. cPositive outgrowth
defined as ≥ 25% of fat pad filled; dpositive outgrowth defined as ≥ 10% of fat pad filled; epositive outgrowth defined as ≥ 3% of fat pad filled.
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a cell subtype-specific fashion. Most important, the follow-
ing parity-induced alterations were observed in mice: (a)
an induction of differentiation and downregulation of the
Wnt/Notch signaling ratio in basal stem/progenitor cells;
(b) a decrease in the in vitro and in vivo proliferation
potential of isolated basal stem/progenitor cells; (c) a
selective downregulation of potentially tumorigenic bio-
functions in the basal stem/progenitor cell subpopulation;
(d) a reduction in estrogen- and progesterone-responsive
and Wnt4-secreting luminal cells; and (e) a rescue of the
proliferation defect in basal stem/progenitor cells in vitro
by recombinant Wnt4. The finding of a decreased Wnt/
Notch signaling ratio provides direct experimental evi-
dence for the hypothesis that early pregnancy changes the
“genomic signature” of mammary stem/progenitor cells
[7], causing their differentiation and reducing their prolif-
eration potential. Furthermore, the data indicate a novel
causal relation between parity-induced reduction in









































































Figure 6 Early pregnancy decreases the proportion of
progesterone receptor (PR) and estrogen receptor a (ERa)-
positive cells. (A) Representative images of immunostaining for PR
and ERa in mammary gland sections from age-matched virgin and
parous mice in estrus. Scale bar, 50 μm. (B) Bar graph comparing
the relative frequency of estrogen- and progesterone receptor-
positive cells between mammary glands of virgin and parous mice.
Data represent the mean ± SD (virgin mice, n = 6; parous mice, n =
5). For PR, P = 3.70E-07; for ERa, P = 0.003, by using two-tailed
unpaired Student t test. (C) qPCR for progesterone receptor (Pgr),
estrogen receptor alpha (Esr1), and the luminal marker keratin 8
(Krt8) genes in total mammary cell suspensions. Data are expressed
as the mean ± SEM from four groups of a minimum of five parous

































































































Figure 7 Effect of Wnt4 on the proliferation capacity of basal
stem/progenitor cells after early pregnancy in mice. (A)
Recombinant Wnt4 rescues the parity-induced in vitro proliferation
defect in basal mammary epithelial cells. Selected mammary
epithelial cells from parous mice were cultured in the absence or
presence of recombinant Wnt4. Three independent experiments
were performed. Data represent the mean ± SEM of colonies per
well, with six to nine wells assessed per cell type. *P ≤ 0.02 (two-
tailed unpaired Student t test). (B) Mechanistic model illustrating
the parity-induced decrease in hormone-sensing and Wnt4-
secreting luminal cells on the Wnt/Notch signaling pathways and
the proliferation/differentiation potential in basal stem/progenitor
cells.
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hormone-sensing and Wnt4-secreting luminal cells and
altered biofunctions in basal stem/progenitor cells.
The basal CD49fHigh cells, as isolated in this study, are
a subfraction of basal epithelial cells [19,21]. Basal
CD49fHigh cells have been demonstrated previously to be
enriched in mammary repopulating units (MRUs)
(known as mammary stem cells (MaSCs)) [16,19] and to
correspond to the Lin- CD24+ CD29High epithelial cell
subpopulation isolated by an alternative method
[18,19,45]. However, the isolated basal CD49fHigh epithe-
lial cell subpopulation represents a heterogeneous cell
fraction containing, in addition to MaSCs, basal progeni-
tor cells and possibly mature myoepithelial cells [45].
Progenitor cells can be characterized in vitro by their col-
ony-formation capacity [22,23], whereas MaSCs have tra-
ditionally been defined by their in vivo regenerative
capacity [16-18]. The observed effects of parity on the in
vitro and in vivo proliferation capacity of the CD49fHigh
cell subpopulation (Table 2) suggests that both basal pro-
genitor cells and basal MaSCs are the target of an early
pregnancy within the mammary epithelium. Although
the dramatic decrease in the in vitro proliferation capa-
city of the CD49fHigh cell subpopulation (Figure 5) indi-
cates a predominant effect of an early pregnancy on basal
progenitor cells, the additional reduction in large in vivo
outgrowths (≥ 10% of fat pad filled) and the prevalence of
rudimentary outgrowths (≥ 3% of fat pad filled) after par-
ity (Table 2) suggest that isolated basal MaSCs are also
affected by an early pregnancy. Because basal mammary
stem and progenitor cells are closely related and likely to
be interdependent in their proliferation potentials, our
data do not permit a definite discrimination between
basal stem and progenitor cells as primary targets of
pregnancy. Therefore, we adhered to the combined term
basal stem/progenitor cells throughout this study.
We found the p53-p21 pathway to be enriched to a simi-
lar extent in all mammary epithelial cell subpopulations
(Additional file 7) [39], and hence, although parity-caused
induction of the p53-p21 pathway may explain the rela-
tively modest decrease in in vitro colony-formation poten-
tial of the luminal Sca1+ cell subpopulation (Figure 5), it
may contribute but cannot account for the almost com-
plete proliferation block in basal stem/progenitor cells. The
most prominent parity-induced alterations in gene expres-
sion in basal stem/progenitor cells were downregulation of
the Wnt-signaling pathway, upregulation of the Notch-
signaling pathway, and upregulation of differentiation
genes. Decreased Wnt signaling in basal stem/progenitor
cells from parous mice was verified on the protein level
by measuring versican and nuclear b-catenin expression
(Figures 3D and 4B, C). Wnt signaling has been shown to
promote long-term expansion of cultured Lin- CD24+
CD29High cells and to provide a competitive advantage in
mammary gland reconstitution assays [43]. The latter is
especially true for the expression of the classic Wnt target
Lgr5 [48], which was found in our study to be downregu-
lated in the basal stem/progenitor cell subpopulation after
parity. Notably, Wnt signaling inhibition was demonstrated
to have an antiproliferative effect in CD29High cells [43].
Furthermore, Notch signaling was observed to reduce in
vitro and in vivo proliferation of CD29High cells while pro-
moting their differentiation [44,49]. Because the differentia-
tion processes of stem and progenitor cells in many organs
and in several model systems are dependent on the Wnt/
Notch signaling ratio [50], an overall reduction in Wnt/
Notch signaling ratio would be expected to have a dramatic
antiproliferation and prodifferentiation effect in mammary
basal stem/progenitor cells. This is exactly what we
observed in the CD49fHigh cell subpopulation of parous
mice. Thereby, the overall conclusion of our study is
strengthened by the fact that all assays used (that is, tran-
scriptome analysis, bioinformatics transcription factor, and
gene-enrichment analyses, in vitro colony-forming assay, in
vivo transplantation assay, and immunohistochemistry)
pointed into the same direction. Thus, analysis of specific
mammary epithelial cell subpopulations allowed the dis-
covery of a decrease in the Wnt/Notch signaling ratio,
which so far is the only plausible explanation for the
observed differentiation burst and dramatic proliferation
block experienced by basal stem/progenitor cells of parous
mice.
As possible explanations for the parity-induced decrease
in Wnt signaling, we found a marked increase in the activ-
ity of the Wnt repressor TCF3 in basal stem/progenitor
cells and a more than threefold reduction in expression of
the secreted Wnt ligand Wnt4 in total mammary cells
from parous mice. The latter corresponded to a similar
decrease in Wnt4-secreting [46] and estrogen and proges-
terone receptor-positive luminal cells. Notably, a similar
decrease in progesterone receptor a-positive cells after
parity has also been observed in human breast epithelium
[51]. Hence, mechanistically, early parity decreases the
hormone responsiveness of the mammary gland in mice
by decreasing the number of estrogen/progesterone recep-
tor-positive luminal cells. This reduces the paracrine
signaling cascade mediated by Wnt4, inducing TCF3-
dependent repression [52] and/or primary downregulation
[47] of canonical Wnt signaling and secondary (reactive)
upregulation of Notch signaling in basal stem/progenitor
cells.
As a final consequence, proliferation is repressed and
basal stem/progenitor cells differentiate. This mechanis-
tic model is supported by the ability of recombinant
Wnt4 to rescue the proliferation defect of basal stem/
progenitor cells from parous mice in vitro (Figure 7).
Our findings in specific mammary epithelial cell sub-
populations are in part consistent with and in part con-
tradictory to studies in entire breasts/mammary glands,
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total mammary cells, or total mammary epithelial cells.
With respect to the transcriptome analysis, our studies
in total mammary cells agree with previous reports in
the entire mammary glands [9,10]. However, in intact
mammary glands or total mammary cells, the additional
presence of stromal and dominant epithelial cell sub-
types might mask the detection of key signaling-pathway
changes. Indeed, our study demonstrates that isolation
of specific mammary epithelial cell subpopulations is a
prerequisite for the detection of a decrease in Wnt/
Notch signaling ratio in basal stem/progenitor cells.
A similar masking effect by stromal and dominant
epithelial cell subtypes (for example, strong clonogenic
luminal Sca1- cells) might also explain why a previous
study with a similar early-pregnancy protocol did not
observe a parity-induced reduction in in vitro prolifera-
tion of total mixed mammary cells [20]. Controversial
results have also been reported with respect to the effect
of parity on the in vivo mammary-repopulating capacity.
Hence, although Britt et al. [21] found no effects of late
pregnancy (9 weeks) on mammary-repopulating units
(MRUs) in total mammary epithelial cells, Siwko et al.
[20] (early-pregnancy protocol) observed a parity-
induced reduction in the mammary-repopulating capa-
city of total mixed mammary cells. With a similar early-
pregnancy protocol and the same cut-off for mammary
gland outgrowth (≥ 10% of fat pad filled), our findings
in isolated mammary basal stem/progenitor cells appear
consistent with the observations of Siwko et al. However,
given that our studies were performed with isolated
mammary basal stem/progenitor cell subpopulations, our
findings are not directly comparable with and neither
confirm nor contradict previous studies using total mam-
mary (epithelial) cells [20,21]. Furthermore, the fact that
the number of smaller outgrowths (≥ 3% of fat pad filled)
was unchanged after parity suggests that MRUs survive
after pregnancy despite their reduced reconstitution effi-
ciency. This conclusion is in line with the recent demon-
stration that Wnt-responsive mammary epithelial stem
cells persist after parity in Axin2 reporter mice [15].
It is intriguing to speculate that marked growth inhibi-
tory effects and the downregulation of canonical Wnt sig-
naling in basal stem/progenitor cells account, at least in
part, for the cancer-protective effect of early pregnancy.
Increases in canonical Wnt signaling have been linked
repeatedly to oncogenesis [53,54]. Moreover, downregula-
tion of the Wnt inhibitory protein Sfrp1 and overexpres-
sion of the Wnt target versican have been associated with
carcinogenesis [55,56]. In the transcriptome analysis
reported here, Sfrp1 was upregulated and versican down-
regulated, thus supporting a parity-induced anticarcino-
genic effect. Moreover, Li et al. [57] showed that
transgenes encoding components of the Wnt signaling
pathway preferentially induce mammary cancers from
progenitor cells. Hence, the contribution of decreased
canonical Wnt signaling in basal stem/progenitor cells to
the cancer-protective effect of early pregnancy may be in
conjunction with other tumor-suppressing mechanisms,
such as parity-induced induction of p53 [58,59]. Thereby,
the increase in the TCF3 repressor activity in basal stem/
progenitor cells is expected to elevate the threshold further
for the activation of tumorigenic Wnt signaling [52]. In
addition to decreased Wnt signaling in basal stem/pro-
genitor cells, decreased ERa- and PR-positive cells could
also be a mechanism for the breast cancer-protective effect
of an early pregnancy. This is especially relevant, given the
specific protective effect of pregnancy against ER/PR-posi-
tive tumors [60].
Furthermore, mammary epithelial cell differentiation per
se has been suggested to exert a breast cancer-protective
effect. This has been challenged, however, by the observa-
tion that differentiation-causing agents such as placental
lactogen and perphenazine failed to protect against carci-
nogenesis in rodents [3,61]. Also, the hypothesis of a
potential breast cancer-protective effect of mammary stro-
mal cells [62] is not supported by our study, because
stromal cells exhibited by far the fewest parity-induced
gene-expression changes. However, our stromal cell sub-
population was not homogenous and devoid of immune
cells, which may have masked some parity-induced altera-
tions. In any case, the parity-induced downregulation of
the Wnt/Notch signaling ratio in basal stem/progenitor
cells represents a possible important mechanism for the
breast cancer-protective effect of early pregnancy.
Conclusions
This study identified downregulation of the Wnt/Notch
signaling ratio in basal stem/progenitor cells as the domi-
nant early parity-induced alteration of gene expression in
mice. This change in gene expression is specific for basal
mammary stem/progenitor cells, is associated with prolif-
eration defects in vitro and in vivo, and is probably caused
by an early parity-induced decrease in hormone-sensitive
and Wnt4-secreting luminal cells. Importantly, because a
similar reduction in progesterone receptor a-positive
luminal cells has been reported in women [51], parity-
induced alterations in Wnt/Notch signaling pathways may
also occur in human basal stem/progenitor cells. Testing
whether Wnt inhibitors mimic early parity-induced breast
cancer protection warrants further investigation.
Additional material
Additional file 1: Flow-cytometric separation of mammary epithelial
cells from virgin control and parous mice. Representative flow-
cytometry pseudocolor plots depicting the first steps in the gating
strategy used to eliminate doublets, cell clumps, dead cells (DAPI bright)
and white blood cells (CD45+) during the procedure for isolating
mammary epithelial cell subpopulations from virgin control (A) and
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parous (B) mice. Subsequent isolation steps are shown in Figure 1. (C)
Bar graph showing the proportion of mammary epithelial cells relative to
the total white blood cell depleted (CD45-) mammary cells. The apparent
modest decrease in total epithelial cells from parous mice was not
significant (P = 0.05 by using two-tailed unpaired Student t test).
Additional file 2: Basal stem/progenitor cells from parous mice
show reduced in vivo proliferation potential. Examples of an
outgrowth (left) and of no outgrowth (right) from basal stem/progenitor
cells of age-matched virgin control mice and of parous mice,
respectively.
Additional file 3: Custom gene set of Wnt target genes. The gene set
is composed of the Wnt targets that have been reported to be
upregulated on canonical Wnt signaling in mammalian systems [64].
Additional file 4: Verification of luminal/basal origin and purity of
isolated mammary epithelial cell subpopulations. (A)
Immunofluorescent staining of isolated mammary epithelial cells with the
luminal marker keratin 18 (Krt18) and the basal marker keratin 14 (Krt14).
Basal myoepithelial cells were negative for Krt18 and positive for Krt14 in
> 95% of total cells. Conversely, luminal Sca1- and luminal Sca1+ cells
were positive for Krt18 and negative for Krt14 in > 95% of total cells.
These data confirm the basal and luminal origin of the isolated cell
subpopulations. Basal stem/progenitor cells were positive for Krt14 and
Krt18 in > 95% and about 20% of total cells, respectively. Data are
representative of three independent experiments. Scale bar, 50 μm. (B/C)
qPCR for CD49f and Sca1 in FACS-sorted mammary epithelial cell
subpopulations. Fold changes are shown relative to myoepithelial cells.
Data are expressed as the mean ± SEM of three independent
experiments.
Additional file 5: Control for complete involution. Representative
images of whole mounts of mammary glands from virgins and parous
mice 28 and 40 days after weaning. Mammary glands were completely
involuted at 28 days and certainly at 40 days after weaning.
Additional file 6: Influence of cell number on transcriptome analysis
and validation of the amplification method. (A) Pairwise correlation
plot of transcriptome data derived from 2,000 and 50,000 myoepithelial
and luminal Sca1- cells, and from 2,000 basal CD49fHigh stem/progenitor
cells isolated from 11-week-old virgin mice (n = 6). Individual arrays were
pairwise correlated by using the unfiltered data as input. Pearson
correlation coefficients were calculated and mapped onto a gray scale
from black (low values) to white (high values). Higher cell numbers
resulted in higher reproducibility, as assessed by high Pearson correlation
coefficients. However, although lower cell numbers resulted in lower
Pearson correlation coefficients, all arrays of one cell subpopulation were
clearly discernible from other subpopulations, irrespective of the cell
number used. Thus, in the range of 2,000 to 50,000 cells, cell-
subpopulation identity was more determining for cluster analyses than
cell number. (B) qPCR on amplified cDNA of mammary epithelial cell
subpopulations. Data were normalized to the reference gene B2M and
are shown relative to 50,000 cells of myoepithelial cells. The basal marker
keratin 14 (Krt14) was expressed by myoepithelial cells and basal
CD49fHigh stem/progenitor cells, but not by luminal Sca1- and luminal
Sca1+ cells. Conversely, the luminal markers keratin 8 (Krt8) and keratin
19 (Krt19) were expressed by luminal Sca1- and luminal Sca1+ cells, but
not by myoepithelial and not by basal CD49fHigh stem/progenitor cells.
As expected, the estrogen receptor alpha (Esr1) was expressed by luminal
Sca1+ cells only. Data represent the means of duplicates. (C) qPCR on
unamplified cDNA. Data were processed and analyzed as in (B). Changes
in expression levels of the luminal and basal markers Krt19 and Krt14,
respectively, were similar to those of amplified cDNA, indicating that the
amplification process was unbiased.
Additional file 7: The decrease in Wnt signaling is specific for basal
stem/progenitor cells, whereas the p53-p21 pathway is upregulated
to the same degree in all mammary epithelial cell subpopulations
from parous mice. (A) Enrichment plots of Wnt target gene-set
enrichment analysis [28,29] for isolated mammary epithelial cell
subpopulations. The enrichment score is plotted against the ranked gene
list, calculated by subtracting the gene expression levels of cells from
age-matched virgins and parous mice. The gene set contained all
canonical Wnt target genes reported in mammalian systems (Additional
file 3). Thus, positive enrichment scores indicate an upregulation, and
negative enrichment scores, a downregulation of Wnt signaling in cells
of parous mice. Statistical analysis indicated specific downregulation of
Wnt signaling in basal stem/progenitor cells from parous mice (Table 1).
The apparent downregulation of Wnt signaling in myoepithelial cells,
which are contaminated with basal stem/progenitor cells, was not
significant. (B) Bar plot of gene-set enrichment analysis (GSEA)-calculated
and normalized enrichment scores for the p53-p21 pathway previously
identified by Sivaraman et al. [39]. The p53-p21 gene set was rendered
by GSEA as significantly upregulated in all isolated mammary epithelial
cell subpopulations from parous mice when testing for all signaling-
pathway gene sets contained in v2.5 and v3.0. The nominal P value, the
false discovery rate (FDR), and the family-wise error rate (FWER) for this
pathway were < 0.01 for all mammary epithelial cell subpopulations;
1,000 permutations were performed with the permutation type “gene
set.” (C) Representative images of immunostaining for p21 and bar graph
comparing the relative frequency of p21-positive epithelial cells in
mammary gland sections from age-matched virgin and parous mice in
estrus. Data represent the mean ± SD (virgin mice: n = 3; parous mice: n
= 3). P = 0.0007, by using two-tailed unpaired Student t test. Scale bar,
25 μm.
Additional file 8: Twenty most significantly downregulated
pathways in basal stem/progenitor cells after parity. The list was
calculated by using v3.0 of GSEA [28]. The 1,000 permutations were
performed by using the permutation type “gene set.” In all other cases,
the default settings were used.
Additional file 9: Blood progesterone concentrations in parous and
age-matched virgin control mice in estrus do not change
significantly. Plasma progesterone levels were measured with ELISA.
Abbreviations
ER: estrogen receptor; FDR: false discovery rate; FWER: family-wise error rate;
GSEA: gene-set enrichment analysis; MARA: motif activity response analysis;
MaSC: mammary stem cell; MRU: mammary repopulating unit; NES:
normalized enrichment score; PR: progesterone receptor; RBC: red blood cell;
WBC: white blood cell.
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